New Gene Editing System Tracks When CRISPR Goes Rogue - The Scientist
New Gene Editing System Tracks When CRISPR Goes Rogue The Scientist
New Gene Editing System Tracks When CRISPR Goes Rogue The Scientist
UK: Gene therapy to now cover synthetic DNA and CRISPR editing BioWorld News
First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy Good News Network
Can genome editing be safer and more effective? Salk Institute
Joint single-cell capture of Cas9 edits and transcriptomes reveals on- and off-target effects on gene expression Nature
Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema NEJM
Little-known protein could protect spinal discs from aging The University of Utah
Chinese scientists fired after child dies in gene editing study: report Fierce Biotech
What China’s Gene-Editing Deaths Reveal About Its Biotech Industry Noema Magazine
Scientists Use AI-Designed CRISPR to Make Disease-Resistant Rice SingularityHub
Lonvo-z CRISPR Therapy Poised for First In Vivo Approval 조선일보
Targeted CD163 Gene Editing Confers Swine Resistance Against Major PRRS Virus Strains Bioengineer.org
One-Year Anniversary of World’s First Personalized CRISPR Gene Therapy for Child with Rare Genetic Disease Children's Hospital of Philadelphia
The application of CRISPR gene-editing technology in influenza prevention and control Frontiers
A quick squeeze gives CRISPR cell reprogramming a boost BioTechniques
A first for CRISPR: powerful prime editing alters DNA directly in the human body Nature
First In Vivo CRISPR Therapy Nears Global Approval 조선일보
UNCOVERseq enables sensitive and controlled gene editing off-target nomination across CRISPR-Cas modalities and systems Nature
Computation and deep-learning-driven advances in CRISPR genome editing Nature
The First In Vivo CRISPR Therapy Could Be Approved by the FDA in 2027 – The Babak Lab Oncodaily
Marrow raises $173M for siRNA drug to compete with one-time CRISPR therapy for sickle cell Endpoints News
CRISPR-A, organoids and autism: searching for a potential preventative BioTechniques
Enhancer-targeted CRISPR-A rescues haploinsufficiency and mutant phenotypes in organoid models of autism Nature
Intellia Therapeutics Preps Gene-Editing Launch as FDA Review Advances TradingView
Intellia Therapeutics (NDQ:NTLA): The World's First Commercial CRISPR Franchise Could Be Closer Than Investors Think Stocks Down Under
Review Assesses Biotechnology and Gene Editing Across Eight Underutilized Solanaceae Species Bioengineer.org
CRISPR-based functional oncology in colorectal cancer: from genome interrogation to precision therapeutic engineering Frontiers
CRISPR Off-Target Edits: Salk's Superb-seq Finds 36 Unintended Sites, One Tied to MYC Gene Changes Tech Times
CRISPR: A Biotech Breakthrough U.S. National Science Foundation (.gov)
Genome Editing in Plant Breeding Bayer
World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children’s Hospital of Philadelphia Children's Hospital of Philadelphia
HKUST Researchers Flip the CRISPR Script to Develop World's First DNA-Guided Gene Editing Tool for Precise Infectious Disease Diagnosis and Advancing Antiviral Therapies HKUST
What is CRISPR? A bioengineer explains Stanford Report
Can Gene Editing Offer A New Treatment Pathway For Inherited Heart Disease? Health and Me
Sickle Cell, Gene Therapy, and the Limits of Medical Triumph American Council on Science and Health
AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds Stanford Medicine
CRISPR-GPT for agentic automation of gene-editing experiments Nature
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 NEJM
Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease NEJM
5 ways CRISPR gene editing is shaping the future of food and health World Economic Forum